Prognostic factors in pediatric acute myeloid leukemia.

Current Hematologic Malignancy Reports
Mohamed RadhiAlan Gamis

Abstract

Acute myeloid leukemia (AML), a heterogeneous group of diseases with variable responses to the same therapy, comprises nearly a quarter of childhood acute leukemias. Although historically very few prognostic markers have been incorporated into therapeutic decision making in AML, recent advances in technology have enabled identification of numerous factors associated with disease outcome. This review provides a detailed analysis of most clinically relevant factors associated with disease outcome in childhood AML.

References

Sep 30, 1999·The New England Journal of Medicine·B LöwenbergA Burnett
Mar 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S M DaviesJ P Perentesis
Jul 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alan S GamisUNKNOWN Children's Cancer Group Study 2891
Oct 9, 2003·British Journal of Haematology·Elaine Coustan-SmithDario Campana
Dec 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonUNKNOWN International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards
Jan 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stefan FröhlingKonstanze Döhner
Apr 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S de BottonP Fenaux
Dec 18, 2004·Current Opinion in Hematology·Irit Avivi, Jacob M Rowe
Jan 13, 2005·JAMA : the Journal of the American Medical Association·Beverly J LangeTodd A Alonzo
Aug 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Guido MarcucciClara D Bloomfield
Mar 16, 2006·Blood·UNKNOWN Children's Oncology GroupStella M Davies
Apr 28, 2006·Pediatric Blood & Cancer·Jeffrey E RubnitzRaul C Ribeiro
Aug 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN MRD-AML-BFM Study GroupDirk Reinhardt
Aug 17, 2006·Blood·Soheil MeshinchiJerald P Radich
Aug 22, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter PaschkaUNKNOWN Cancer and Leukemia Group B
Apr 5, 2007·The Oncologist·Soheil Meshinchi, Robert J Arceci
Nov 21, 2007·Haematologica·Gertjan J L Kaspers, Christian M Zwaan
Jun 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter PaschkaClara D Bloomfield
Jul 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Luca MaurilloAdriano Venditti
Aug 6, 2008·Pediatric Blood & Cancer·Lillian SungUNKNOWN Children's Oncology Group
Aug 13, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dimitri A BreemsBob Löwenberg
Dec 2, 2008·Best Practice & Research. Clinical Haematology·Charles A Schiffer
Dec 5, 2009·Best Practice & Research. Clinical Haematology·Richard M Stone
Dec 17, 2009·Hematology·David Grimwade, Robert K Hills
Dec 30, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frederik DammJürgen Krauter

❮ Previous
Next ❯

Citations

Jun 13, 2013·Current Oncology Reports·M Monica Gramatges, Karen R Rabin
Sep 29, 2012·Journal of Pediatric Hematology/oncology·Anne ReillyKathleen E Sullivan
Mar 17, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Soheil MeshinchiJ Milburn Jessup
Jul 1, 2015·Leukemia & Lymphoma·Babak Asadi-AzarbaijaniKirsi Jahnukainen
Jul 14, 2012·Advances in Pediatrics·Kelly W MaloneyStephen P Hunger
Aug 21, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Tal SchechterHaydar Frangoul
Dec 21, 2012·Pediatric Blood & Cancer·Alan S GamisUNKNOWN COG Acute Myeloid Leukemia Committee
Aug 21, 2012·Leukemia Research·Youqi HanMark D Minden
Mar 29, 2014·Frontiers in Oncology·Sarah K TasianRichard Aplenc
May 7, 2016·Genes, Chromosomes & Cancer·Anne Cathrine Lund LaursenHenrik Hasle

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.